Becton Dickinson Operating Margin 2012-2026 | BDX
Current and historical operating margin for Becton Dickinson (BDX) over the last 10 years. The current operating profit margin for Becton Dickinson as of June 30, 2026 is 17.60%.
| Becton Dickinson Operating Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Operating Income | Operating Margin |
| 2026-06-30 | $22.42B | $2.31B | 10.30% |
| 2026-03-31 | $22.16B | $2.38B | 10.76% |
| 2025-12-31 | $21.92B | $2.68B | 12.20% |
| 2025-09-30 | $21.84B | $2.58B | 11.80% |
| 2025-06-30 | $19.81B | $2.20B | 11.11% |
| 2025-03-31 | $20.08B | $2.06B | 10.28% |
| 2024-12-31 | $20.64B | $2.41B | 11.70% |
| 2024-09-30 | $20.18B | $2.40B | 11.88% |
| 2024-06-30 | $19.83B | $2.13B | 10.72% |
| 2024-03-31 | $19.72B | $2.07B | 10.50% |
| 2023-12-31 | $19.49B | $1.96B | 10.07% |
| 2023-09-30 | $19.37B | $2.11B | 10.90% |
| 2023-06-30 | $19.05B | $2.25B | 11.81% |
| 2023-03-31 | $18.81B | $2.24B | 11.90% |
| 2022-12-31 | $18.74B | $2.18B | 11.62% |
| 2022-09-30 | $18.87B | $2.28B | 12.10% |
| 2022-06-30 | $18.41B | $1.88B | 10.20% |
| 2022-03-31 | $18.38B | $1.83B | 9.97% |
| 2021-12-31 | $18.53B | $1.70B | 9.17% |
| 2021-09-30 | $19.13B | $2.25B | 11.77% |
| 2021-06-30 | $18.57B | $1.85B | 9.96% |
| 2021-03-31 | $17.82B | $1.72B | 9.64% |
| 2020-12-31 | $17.16B | $1.65B | 9.63% |
| 2020-09-30 | $16.07B | $0.91B | 5.67% |
| 2020-06-30 | $16.92B | $1.34B | 7.93% |
| 2020-03-31 | $17.41B | $1.61B | 9.23% |
| 2019-12-31 | $17.36B | $1.38B | 7.92% |
| 2019-09-30 | $17.29B | $1.76B | 10.18% |
| 2019-06-30 | $17.11B | $2.22B | 13.00% |
| 2019-03-31 | $17.04B | $2.11B | 12.38% |
| 2018-12-31 | $17.06B | $2.16B | 12.66% |
| 2018-09-30 | $15.98B | $1.51B | 9.44% |
| 2018-06-30 | $14.75B | $1.42B | 9.66% |
| 2018-03-31 | $13.50B | $0.69B | 5.10% |
| 2017-12-31 | $12.25B | $0.95B | 7.73% |
| 2017-09-30 | $12.09B | $1.52B | 12.59% |
| 2017-06-30 | $12.16B | $1.13B | 9.28% |
| 2017-03-31 | $12.32B | $1.87B | 15.16% |
| 2016-12-31 | $12.42B | $1.89B | 15.20% |
| 2016-09-30 | $12.48B | $1.43B | 11.46% |
| 2016-06-30 | $12.31B | $1.63B | 13.22% |
| 2016-03-31 | $12.23B | $1.25B | 10.21% |
| 2015-12-31 | $11.22B | $1.08B | 9.60% |
| 2015-09-30 | $10.28B | $1.07B | 10.45% |
| 2015-06-30 | $9.42B | $1.18B | 12.52% |
| 2015-03-31 | $8.46B | $1.49B | 17.60% |
| 2014-12-31 | $8.48B | $1.58B | 18.59% |
| 2014-09-30 | $8.45B | $1.61B | 19.01% |
| 2014-06-30 | $8.35B | $1.28B | 15.36% |
| 2014-03-31 | $8.24B | $1.24B | 15.06% |
| 2013-12-31 | $8.17B | $1.24B | 15.19% |
| 2013-09-30 | $8.05B | $1.26B | 15.58% |
| 2013-06-30 | $7.92B | $1.57B | 19.79% |
| 2013-03-31 | $7.85B | $1.61B | 20.53% |
| 2012-12-31 | $7.78B | $1.61B | 20.74% |
| 2012-09-30 | $7.71B | $1.56B | 20.21% |
| 2012-06-30 | $7.61B | $1.53B | 20.14% |
| 2012-03-31 | $7.58B | $1.53B | 20.20% |
| 2011-12-31 | $7.57B | $1.59B | 20.97% |
| 2011-09-30 | $7.58B | $1.66B | 21.94% |
| 2011-06-30 | $7.34B | $1.62B | 22.01% |
| 2011-03-31 | $7.22B | $1.59B | 22.05% |
| 2010-12-31 | $7.10B | $1.57B | 22.07% |
| 2010-09-30 | $7.12B | $1.58B | 22.22% |
| 2010-06-30 | $7.22B | $1.65B | 22.79% |
| 2010-03-31 | $7.21B | $1.66B | 22.95% |
| 2009-12-31 | $7.14B | $1.60B | 22.44% |
| 2009-09-30 | $6.99B | $1.59B | 22.76% |
| 2009-06-30 | $6.86B | $1.55B | 22.55% |
| 2009-03-31 | $6.89B | $1.52B | 22.11% |
| 2008-12-31 | $6.91B | $1.54B | 22.34% |
| 2008-09-30 | $6.90B | $1.49B | 21.59% |
| 2008-06-30 | $6.88B | $1.48B | 21.50% |
| 2008-03-31 | $6.66B | $1.40B | 21.00% |
| 2007-12-31 | $6.49B | $1.33B | 20.56% |
| 2007-09-30 | $6.28B | $1.19B | 18.86% |
| 2007-06-30 | $6.17B | $1.15B | 18.68% |
| 2007-03-31 | $6.00B | $1.11B | 18.54% |
| 2006-12-31 | $5.85B | $1.05B | 17.88% |
| 2006-09-30 | $5.74B | $1.14B | 19.90% |
| 2006-06-30 | $5.58B | $1.15B | 20.52% |
| 2006-03-31 | $5.51B | $1.12B | 20.35% |
| 2005-12-31 | $5.45B | $1.12B | 20.64% |
| 2005-09-30 | $5.34B | $1.06B | 19.92% |
| 2005-06-30 | $5.29B | $1.02B | 19.31% |
| 2005-03-31 | $5.15B | $0.90B | 17.38% |
| 2004-12-31 | $5.04B | $0.87B | 17.27% |
| 2004-09-30 | $4.94B | $0.79B | 15.95% |
| 2004-06-30 | $4.79B | $0.77B | 15.98% |
| 2004-03-31 | $4.72B | $0.80B | 17.05% |
| 2003-12-31 | $4.60B | $0.77B | 16.78% |
| 2003-09-30 | $4.46B | $0.76B | 17.05% |
| 2003-06-30 | $4.36B | $0.72B | 16.53% |
| 2003-03-31 | $4.19B | $0.71B | 17.00% |
| 2002-12-31 | $4.07B | $0.69B | 16.99% |
| 2002-09-30 | $3.96B | $0.68B | 17.05% |
| 2002-06-30 | $3.94B | $0.67B | 16.86% |
| 2002-03-31 | $3.89B | $0.67B | 17.13% |
| 2001-12-31 | $3.83B | $0.66B | 17.19% |
| 2001-09-30 | $3.75B | $0.64B | 17.03% |
| 2001-06-30 | $3.68B | $0.61B | 16.48% |
| 2001-03-31 | $3.65B | $0.59B | 16.17% |
| 2000-12-31 | $3.62B | $0.57B | 15.79% |
| 2000-09-30 | $3.62B | $0.57B | 15.81% |
| 2000-06-30 | $3.60B | $0.56B | 15.53% |
| 2000-03-31 | $3.56B | $0.54B | 15.09% |
| 1999-12-31 | $3.51B | $0.53B | 15.14% |
| 1999-09-30 | $3.42B | $0.52B | 15.21% |
| 1999-06-30 | $3.36B | $0.53B | 15.87% |
| 1999-03-31 | $3.32B | $0.50B | 15.15% |
| 1998-12-31 | $3.18B | $0.50B | 15.83% |
| 1998-09-30 | $3.12B | $0.50B | 15.91% |
| 1998-06-30 | $3.02B | $0.48B | 16.01% |
| 1998-03-31 | $2.90B | $0.49B | 16.92% |
| 1997-12-31 | $2.86B | $0.47B | 16.35% |
| 1997-09-30 | $2.81B | $0.45B | 16.01% |
| 1997-06-30 | $2.79B | $0.44B | 15.72% |
| 1997-03-31 | $2.78B | $0.45B | 16.34% |
| 1996-12-31 | $2.79B | $0.45B | 15.97% |
| 1996-09-30 | $2.77B | $0.43B | 15.56% |
| 1996-06-30 | $2.76B | $0.43B | 15.43% |
| 1996-03-31 | $2.77B | $0.42B | 15.01% |
| 1995-12-31 | $2.76B | $0.41B | 14.82% |
| 1995-09-30 | $2.71B | $0.40B | 14.64% |
| 1995-06-30 | $2.71B | $0.40B | 14.59% |
| 1995-03-31 | $2.66B | $0.38B | 14.30% |
| 1994-12-31 | $2.60B | $0.37B | 14.12% |
| 1994-09-30 | $2.56B | $0.36B | 13.91% |
| 1994-06-30 | $2.51B | $0.32B | 12.71% |
| 1994-03-31 | $2.48B | $0.31B | 12.37% |
| 1993-12-31 | $2.46B | $0.29B | 11.92% |
| 1993-09-30 | $2.47B | $0.30B | 12.05% |
| 1993-06-30 | $2.48B | $0.32B | 13.02% |
| 1993-03-31 | $2.45B | $0.33B | 13.49% |
| 1992-12-31 | $2.43B | $0.34B | 13.94% |
| 1992-09-30 | $2.37B | $0.33B | 13.91% |
| 1992-06-30 | $2.26B | $0.31B | 13.84% |
| 1992-03-31 | $2.23B | $0.30B | 13.66% |
| 1991-12-31 | $2.19B | $0.30B | 13.87% |
| 1991-09-30 | $2.17B | $0.31B | 14.46% |
| 1991-06-30 | $2.16B | $0.32B | 14.95% |
| 1991-03-31 | $2.10B | $0.32B | 15.17% |
| 1990-12-31 | $2.07B | $0.31B | 15.19% |
| 1990-09-30 | $2.01B | $0.31B | 15.14% |
| 1990-06-30 | $1.95B | $0.29B | 14.69% |
| 1990-03-31 | $1.89B | $0.27B | 14.42% |
| 1989-12-31 | $1.84B | $0.26B | 14.11% |
| 1989-09-30 | $1.81B | $0.26B | 14.07% |
| 1989-06-30 | $1.68B | $0.24B | 13.97% |
| 1989-03-31 | $1.72B | $0.24B | 14.15% |
| 1988-12-31 | $1.72B | $0.24B | 14.03% |
| 1988-09-30 | $1.71B | $0.24B | 13.98% |
| 1988-06-30 | $1.80B | $0.25B | 13.98% |
| 1988-03-31 | $1.71B | $0.24B | 14.04% |
| 1987-12-31 | $1.64B | $0.23B | 14.06% |
| 1987-09-30 | $1.58B | $0.22B | 13.90% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical & Dental Supplies | $51.228B | $21.840B |
| Becton, Dickinson and Company, is a medical technology company engaged principally in the development, manufacture and sale of medical devices, instrument systems and reagents. BD's operations consisted of three business segments: BD Medical, BD Diagnostics and BD Biosciences. The company's organizational structure was realigned to form two principal business segments: BD Medical, BD Life Sciences and BD Interventional. BD Medical: BD Medical's major product lines include needles, syringes and intravenous catheters for medication delivery and generic prefilled injectables. BD Life Sciences - BD Diagnostics provides products for the safe collection and transport of diagnostics specimens to detect a broad range of infectious diseases, healthcare-associated infections and cancer. BD Biosciences produces research and clinical tools that facilitate the study of cells to gain a better understanding of normal and disease processes. With the acquisition of C.R. Bard, BD added a new segment - BD Interventional. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| McKesson (MCK) | United States | $104.880B | 22.04 |
| Cardinal Health (CAH) | United States | $54.109B | 20.66 |
| West Pharmaceutical Services (WST) | United States | $25.687B | 42.94 |
| Straumann Holding AG (SAUHY) | Switzerland | $18.592B | 0.00 |
| Align Technology (ALGN) | United States | $10.528B | 16.28 |
| Cooper (COO) | United States | $10.130B | 11.56 |
| Henry Schein (HSIC) | United States | $9.754B | 16.48 |
| Merit Medical Systems (MMSI) | United States | $5.146B | 23.48 |
| DENTSPLY SIRONA (XRAY) | United States | $1.960B | 6.87 |
| CONMED (CNMD) | United States | $1.406B | 9.82 |
| STAAR Surgical (STAA) | United States | $1.125B | 35.07 |
| Pro-Dex (PDEX) | United States | $0.214B | 19.97 |
| Lifevantage (LFVN) | United States | $0.077B | 11.04 |